Literature DB >> 1846157

Subcutaneous fluid administration in elderly subjects: validation of an under-used technique.

S Lipschitz1, A J Campbell, M S Roberts, S Wanwimolruk, E G McQueen, M McQueen, L A Firth.   

Abstract

In a crossover study in six volunteers over the age of 65, absorption of 500 mL of normal saline given subcutaneously was compared with that given intravenously. Tritiated water and technetium pertechnetate were used as water tracers. Tritium radioisotope levels in the blood increased in a smooth curve during subcutaneous infusion, reaching equilibrium levels within 60 minutes. The area under the curve after subcutaneous infusion was almost identical to that after intravenous infusion in all subjects. Radioactivity could not be demonstrated at the subcutaneous site 1 hour after completion of the infusion. Subcutaneous infusion is an effective method of giving fluid to elderly people and deserves more widespread use.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1846157     DOI: 10.1111/j.1532-5415.1991.tb05898.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  13 in total

1.  Assessment of sterility in fluid bags maintained for chronic use.

Authors:  Kristin A Matthews; Douglas K Taylor
Journal:  J Am Assoc Lab Anim Sci       Date:  2011-09       Impact factor: 1.232

2.  Modeling of subcutaneous absorption kinetics of infusion solutions in the elderly using technetium.

Authors:  M S Roberts; S Lipschitz; A J Campbell; S Wanwimolruk; E G McQueen; M McQueen
Journal:  J Pharmacokinet Biopharm       Date:  1997-02

3.  [Subcutaneous infusions for geriatric patients: rediscovery of an "old" technique].

Authors:  A H Leischker
Journal:  Z Gerontol Geriatr       Date:  2012-10       Impact factor: 1.281

Review 4.  Subcutaneous hydration by hypodermoclysis. A practical and low cost treatment for elderly patients.

Authors:  A Frisoli Junior; A P de Paula; D Feldman; F Nasri
Journal:  Drugs Aging       Date:  2000-04       Impact factor: 3.923

Review 5.  Review of the mechanism of action and clinical efficacy of recombinant human hyaluronidase coadministration with current prandial insulin formulations.

Authors:  Douglas B Muchmore; Daniel E Vaughn
Journal:  J Diabetes Sci Technol       Date:  2010-03-01

6.  Hyaluronidase significantly enhances the efficacy of regional vinblastine chemotherapy of malignant melanoma.

Authors:  T Spruss; G Bernhardt; H Schönenberger; W Schiess
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

7.  Temporary Lumbar Subcutaneous Cerebrospinal Fluid Shunt Placement in Pediatric Patient: A Technical Note.

Authors:  Adnan I Qureshi; WeiGang Xiao
Journal:  J Vasc Interv Neurol       Date:  2016-01

8.  Comparison of the tolerability of recombinant human hyaluronidase + normal saline and recombinant human hyaluronidase + lactated ringer's solution administered subcutaneously: A phase IV, double-blind, randomized pilot study in healthy volunteers.

Authors:  Samuel S Dychter; David Ebel; Tonya R Mead; Richard C Yocum
Journal:  Curr Ther Res Clin Exp       Date:  2009-12

Review 9.  Drug structure-transport relationships.

Authors:  Michael S Roberts
Journal:  J Pharmacokinet Pharmacodyn       Date:  2010-11-24       Impact factor: 2.745

10.  Subcutaneous injection-induced cellulites.

Authors:  Kao-Chi Cheng; Po-Tsung Huang; Chiu-Shong Liu; Wen-Yuan Lin
Journal:  Biomedicine (Taipei)       Date:  2017-06-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.